Quantum Genesis AI Corp. Reports No Revenue and Significant Losses in Latest Financial Filing

Quantum Genesis AI Corp., formerly known as Quantumzyme Corp., reported significant financial challenges in its latest 10-Q filing for the quarter ending January 31, 2026. The company recorded no revenue for both the quarter and the six months ended January 31, 2026, mirroring the same period in the previous fiscal year. Operating expenses for the quarter were $1,382, a notable decrease from $24,534 in the prior year, primarily due to reduced professional fees. However, the company faced substantial losses, with a net loss of $4,329,657 for the quarter, compared to a loss of $29,806 in the same quarter of the previous year. For the six-month period, the net loss was $4,379,525, significantly higher than the $89,329 loss reported in the prior year.

The company’s financial position showed a working capital deficit of $418,342 as of January 31, 2026, with total current assets of only $59 against total current liabilities of $418,401. This represents a decrease in total liabilities from $441,301 as of July 31, 2025. The accumulated deficit increased to $10,016,092, reflecting ongoing financial difficulties. The company’s cash position also deteriorated, ending the period with just $59 in cash, down from $584 at the end of the previous fiscal period.

Strategically, Quantum Genesis AI Corp. underwent a name change from Quantumzyme Corp. in February 2026, following a series of organizational changes that included the acquisition of assets from Quantumzyme Inc. in 2023. The company issued 2,010,000 shares of common stock valued at $4,401,900 to settle $60,300 in notes payable and $15,728 in accrued interest, resulting in a significant loss on the settlement of debt. The company’s total stockholders' deficit improved slightly to $(418,342) from $(440,717) in the previous period, attributed to the issuance of new shares.

Operationally, the company has not reported any customer counts or user statistics, indicating a lack of market penetration or product adoption. The absence of revenue and the ongoing losses raise concerns about the company's ability to sustain operations without securing additional funding. The management highlighted the need for external financing to continue operations, as they currently have no firm agreements in place for future funding. The company’s ability to attract investment will be critical for its survival and potential growth.

Looking ahead, Quantum Genesis AI Corp. faces substantial uncertainty regarding its future operations. The management has expressed concerns about the company's ability to continue as a going concern, emphasizing the need for funding to support its business model and operational activities. Without sufficient capital, the company may be forced to curtail its development plans, which could adversely affect its business prospects and shareholder value.